BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 16434897)

  • 1. ALK-positive anaplastic large cell lymphoma mimicking nodular sclerosis Hodgkin's lymphoma: report of 10 cases.
    Vassallo J; Lamant L; Brugieres L; Gaillard F; Campo E; Brousset P; Delsol G
    Am J Surg Pathol; 2006 Feb; 30(2):223-9. PubMed ID: 16434897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients.
    Kagami Y; Suzuki R; Taji H; Yatabe Y; Takeuchi T; Maeda S; Kondo E; Kojima M; Motoori T; Mizoguchi Y; Okamoto M; Ohnishi K; Yamabe H; Seto M; Ogura M; Koshikawa T; Takahashi T; Kurita S; Morishima Y; Suchi T; Nakamura S
    Am J Surg Pathol; 1999 Oct; 23(10):1184-200. PubMed ID: 10524519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC1 (EMA) is preferentially expressed by ALK positive anaplastic large cell lymphoma, in the normally glycosylated or only partly hypoglycosylated form.
    ten Berge RL; Snijdewint FG; von Mensdorff-Pouilly S; Poort-Keesom RJ; Oudejans JJ; Meijer JW; Willemze R; Hilgers J; Meijer CJ
    J Clin Pathol; 2001 Dec; 54(12):933-9. PubMed ID: 11729213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining.
    Lamant L; Meggetto F; al Saati T; Brugières L; de Paillerets BB; Dastugue N; Bernheim A; Rubie H; Terrier-Lacombe MJ; Robert A; Rigal F; Schlaifer D; Shiuta M; Mori S; Delsol G
    Blood; 1996 Jan; 87(1):284-91. PubMed ID: 8547653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathologic features of 66 cases of anaplastic lymphoma kinase positive and negative systemic anaplastic large cell lymphoma: a comparative study].
    Shi Y; Chen G; Zhou XG; Gong LP; Yu R; Zheng YY; Xie JL; Jin Y
    Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):235-9. PubMed ID: 20654121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and characterization of anaplastic large cell lymphoma and its association with Epstein-Barr virus in Pakistani patients.
    Noorali S; Pervez S; Yaqoob N; Moatter T; Nasir MI; Haroon S; Hodges E; Smith JL
    Pathol Res Pract; 2004; 200(10):669-79. PubMed ID: 15648604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hodgkin-like anaplastic large cell lymphoma (previously designated in the REAL classification) has same immunophenotypic features to classical Hodgkin lymphoma.
    Tamaru J; Tokuhira M; Nittsu N; Nakamura S; Ichinohasama R; Suzuki R; Mori H; Takagi T; Suzuki T; Itami J; Itoyama S; Mikata A
    Leuk Lymphoma; 2007 Jun; 48(6):1127-38. PubMed ID: 17577776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic molecule expression is predictive of prognosis in Hodgkin's-like anaplastic large cell lymphoma.
    Asano N; Suzuki R; Matsuo K; Kagami Y; Ishida F; Tamaru JI; Jin GS; Sato Y; Shimoyama Y; Yoshino T; Morishima Y; Nakamura S
    Histopathology; 2007 May; 50(6):705-15. PubMed ID: 17493234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hodgkin lymphoma with unusual intrasinusoidal pattern of infiltration.
    Lee SS; Ryoo BY; Park YH; Park S; Kim MS; Park KH; Kim CW
    Leuk Lymphoma; 2004 Oct; 45(10):2135-41. PubMed ID: 15370261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80(NPM/ALK) expression.
    Nakamura S; Shiota M; Nakagawa A; Yatabe Y; Kojima M; Motoori T; Suzuki R; Kagami Y; Ogura M; Morishima Y; Mizoguchi Y; Okamoto M; Seto M; Koshikawa T; Mori S; Suchi T
    Am J Surg Pathol; 1997 Dec; 21(12):1420-32. PubMed ID: 9414185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of Epstein-Barr virus in anaplastic large cell lymphoma: a study of 64 cases classified according to World Health Organization criteria.
    Herling M; Rassidakis GZ; Jones D; Schmitt-Graeff A; Sarris AH; Medeiros LJ
    Hum Pathol; 2004 Apr; 35(4):455-9. PubMed ID: 15116326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1.
    Pulford K; Lamant L; Morris SW; Butler LH; Wood KM; Stroud D; Delsol G; Mason DY
    Blood; 1997 Feb; 89(4):1394-404. PubMed ID: 9028963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.
    Laurent C; Delas A; Gaulard P; Haioun C; Moreau A; Xerri L; Traverse-Glehen A; Rousset T; Quintin-Roue I; Petrella T; Emile JF; Amara N; Rochaix P; Chenard-Neu MP; Tasei AM; Menet E; Chomarat H; Costes V; Andrac-Meyer L; Michiels JF; Chassagne-Clement C; de Leval L; Brousset P; Delsol G; Lamant L
    Ann Oncol; 2016 Feb; 27(2):306-14. PubMed ID: 26598546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma.
    Peh SC; Kim LH; Poppema S
    Am J Surg Pathol; 2001 Jul; 25(7):925-9. PubMed ID: 11420464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
    Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fascin expression in diffuse large B-cell lymphoma, anaplastic large cell lymphoma, and classical Hodgkin lymphoma.
    Bakshi NA; Finn WG; Schnitzer B; Valdez R; Ross CW
    Arch Pathol Lab Med; 2007 May; 131(5):742-7. PubMed ID: 17488159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD26, together with cell surface adenosine deaminase, is selectively expressed on ALK-positive, but not on ALK-negative, anaplastic large cell lymphoma and Hodgkin's lymphoma.
    Kameoka J; Ichinohasama R; Inoue H; Yamamoto J; Yokoyama H; Tomiya Y; Yamada M; Ishizawa K; Harigae H; Sawai T; Sasaki T
    Leuk Lymphoma; 2006 Oct; 47(10):2181-8. PubMed ID: 17071493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALK-positive lymphoma: a single disease with a broad spectrum of morphology.
    Benharroch D; Meguerian-Bedoyan Z; Lamant L; Amin C; Brugières L; Terrier-Lacombe MJ; Haralambieva E; Pulford K; Pileri S; Morris SW; Mason DY; Delsol G
    Blood; 1998 Mar; 91(6):2076-84. PubMed ID: 9490693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of carbohydrate antigens, p80NPM/ALK, cytotoxic cell-associated antigens, and Epstein-Barr virus gene products in anaplastic large cell lymphomas.
    Kasai K; Kon S; Kikuchi K; Sato Y; Kameya T
    Pathol Int; 1998 Mar; 48(3):171-8. PubMed ID: 9589484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements.
    Pittaluga S; Wlodarska I; Pulford K; Campo E; Morris SW; Van den Berghe H; De Wolf-Peeters C
    Am J Pathol; 1997 Aug; 151(2):343-51. PubMed ID: 9250148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.